These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23039309)

  • 1. MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia.
    De Paoli L; Cerri M; Monti S; Rasi S; Spina V; Bruscaggin A; Greco M; Ciardullo C; Famà R; Cresta S; Maffei R; Ladetto M; Martini M; Laurenti L; Forconi F; Marasca R; Larocca LM; Bertoni F; Gaidano G; Rossi D
    Leuk Lymphoma; 2013 May; 54(5):1087-90. PubMed ID: 23039309
    [No Abstract]   [Full Text] [Related]  

  • 2. MYC addiction in chronic lymphocytic leukemia.
    Rossi D
    Leuk Lymphoma; 2013 May; 54(5):905-6. PubMed ID: 23339445
    [No Abstract]   [Full Text] [Related]  

  • 3. Multi-Omics Analysis Identifies MGA as a Negative Regulator of the MYC Pathway in Lung Adenocarcinoma.
    Llabata P; Mitsuishi Y; Choi PS; Cai D; Francis JM; Torres-Diz M; Udeshi ND; Golomb L; Wu Z; Zhou J; Svinkina T; Aguilera-Jimenez E; Liu Y; Carr SA; Sanchez-Cespedes M; Meyerson M; Zhang X
    Mol Cancer Res; 2020 Apr; 18(4):574-584. PubMed ID: 31862696
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Iyer P; Zhang B; Liu T; Jin M; Hart K; Zhang J; Siegert V; Remke M; Wang X; Yu L; Song J; Venkataraman G; Chan WC; Jia Z; Buchner M; Siddiqi T; Rosen ST; Danilov A; Wang L
    Sci Transl Med; 2024 Jul; 16(758):eadg7915. PubMed ID: 39083585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRF4 L116R mutation promotes proliferation of chronic lymphocytic leukemia B cells inducing MYC.
    Benatti S; Atene CG; Fiorcari S; Mesini N; Martinelli S; Zucchini P; Bacchelli F; Maccaferri M; Debbia G; Potenza L; Rossi D; Vallisa D; Trentin L; Gaidano G; Luppi M; Marasca R; Maffei R
    Hematol Oncol; 2021 Dec; 39(5):707-711. PubMed ID: 34431535
    [No Abstract]   [Full Text] [Related]  

  • 6. High expression of c-Myc in chronic lymphocytic leukaemia with t(8;14)(q24.1;q32): A case report.
    Nagaharu K; Izumi T; Ueda M; Usui E; Shikami M; Ohishi K; Tamaki S
    Leuk Res; 2020 Sep; 96():106424. PubMed ID: 32721643
    [No Abstract]   [Full Text] [Related]  

  • 7. ID helix-loop-helix proteins as determinants of cell survival in B-cell chronic lymphocytic leukemia cells in vitro.
    Weiler S; Ademokun JA; Norton JD
    Mol Cancer; 2015 Feb; 14(1):30. PubMed ID: 25644253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYC network mutations in high-risk chronic lymphocytic leukaemia.
    Monti S; Deambrogi C; Rinaldi A; Bertoni F; Gaidano G; Rossi D
    Hematol Oncol; 2014 Sep; 32(3):155-7. PubMed ID: 24449520
    [No Abstract]   [Full Text] [Related]  

  • 9. Proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC gene.
    Gibson SE; Leeman-Neill RJ; Jain S; Piao W; Cieply KM; Swerdlow SH
    Br J Haematol; 2016 Oct; 175(1):173-5. PubMed ID: 26568397
    [No Abstract]   [Full Text] [Related]  

  • 10. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.
    Sharma VM; Calvo JA; Draheim KM; Cunningham LA; Hermance N; Beverly L; Krishnamoorthy V; Bhasin M; Capobianco AJ; Kelliher MA
    Mol Cell Biol; 2006 Nov; 26(21):8022-31. PubMed ID: 16954387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
    Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia.
    Guo XL; Pan L; Zhang XJ; Suo XH; Niu ZY; Zhang JY; Wang F; Dong ZR; Da W; Ohno R
    Leuk Lymphoma; 2007 Jun; 48(6):1200-7. PubMed ID: 17577784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc modulates c-Myc/Mad1 balance in human leukemia cells.
    Sirinian MI; Pisegna S; Paroli M; Militi S; Testa U; Peschle C
    Leukemia; 2003 Jan; 17(1):272-4. PubMed ID: 12529695
    [No Abstract]   [Full Text] [Related]  

  • 14. Copy number alterations unmasked as enhancer hijackers.
    Beroukhim R; Zhang X; Meyerson M
    Nat Genet; 2016 Dec; 49(1):5-6. PubMed ID: 28029156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Richter transformation with c-MYC overexpression: report of three cases.
    Wang L; Aghel A; Peterson B; Wang-Rodriguez J; Wang HY; Zhao XF
    Int J Clin Exp Pathol; 2015; 8(6):7540-6. PubMed ID: 26261666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Myc is regulated by HIF-2α in chronic hypoxia and influences sensitivity to 5-FU in colon cancer.
    Wang L; Xue M; Chung DC
    Oncotarget; 2016 Nov; 7(48):78910-78917. PubMed ID: 27793037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylprednisolone suppresses the Wnt signaling pathway in chronic lymphocytic leukemia cell line MEC-1 regulated by LEF-1 expression.
    Yao QM; Li PP; Liang SM; Lu K; Zhu XJ; Liu YX; Zhang F; Yuan T; Wang X
    Int J Clin Exp Pathol; 2015; 8(7):7921-8. PubMed ID: 26339357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia.
    Kaufman KL; Jenkins Y; Alomari M; Mirzaei M; Best OG; Pascovici D; Mactier S; Mulligan SP; Haynes PA; Christopherson RI
    Oncotarget; 2015 Dec; 6(38):40981-97. PubMed ID: 26556860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
    Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
    Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.